Abstract
BAK-free and preservative-free therapies are becoming available but are not always a feasible alternative. It is important to recognize different clinical manifestations of allergy and chronic inflammation and to discuss options for patients experiencing OSD.
Original language | English (US) |
---|---|
Pages (from-to) | 136-143 |
Number of pages | 8 |
Journal | Current opinion in ophthalmology |
Volume | 24 |
Issue number | 2 |
DOIs | |
State | Published - Mar 1 2013 |
Keywords
- Benzalkonium Chloride
- Glaucoma
- Ocular Surface Disease
- Preservatives
- Recommendations
ASJC Scopus subject areas
- Ophthalmology